Furthermore, we report that IGF2 expression decreases in the hippocampus of patients with Alzheimer's disease, and this leads us to hypothesize that increased IGF2 levels may be beneficial for treating the disease. The gene discussed is IGF2; the disease is early-onset autosomal dominant Alzheimer disease.